Skip to main content

Closed

REVB: Revelation Biosciences, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.39×avg

Market Cap

3.71MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Revelation Biosciences, Inc.

REVBNASDAQ Capital Market·USD·Closed

Revelation Biosciences, Inc.

REVBNASDAQ·USD·Closed

$0.95

−4.56%

$0.95

−$0.05 (4.56%)

52W Range

1thpctl

Volume

0.39×avg

Mkt Cap

3.71MUSD

P/E

-0.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings